Ann & Robert H. Lurie Children's Hospital of Chicago issued the following announcement on Feb. 19.
Interventional cardiologists Paul Tannous, MD, PhD, and Alan Nugent, MBBS, were the first in Illinois to implant a new FDA-approved device that closes a hole in the wall between the two upper chambers of the heart – permanently fixing one of the most common forms of congenital heart disease, the atrial septal defect (ASD). The procedure is minimally invasive, and for patients, like Jovanny who was the first to receive the device, are able to go home within 24 hours.
The new device (called GORE® Cardioform ASD Occluder) conforms to the patient’s unique anatomy and can safely close large openings (up to 35 mm or 1.4 inches in diameter).
“Because of the expanded size range and excellent safety record, some ASDs that previously required open heart surgery can now be closed using this minimally invasive approach,” said Dr. Tannous.
Learn more about our interventional cardiology team: https://bit.ly/2UGguS3.
Original source can be found here.
Source: Ann & Robert H. Lurie Children's Hospital of Chicago